The BPC-157/TB-500 blend combines two of the most extensively studied regenerative peptides into a single 20mg vial: Body Protection Compound-157 (BPC-157, 10mg) and Thymosin Beta-4 fragment (TB-500, 10mg)
Typical Protocol: Commonly cited protocols use 1.5-1.6 mg subcutaneously two to three times per week (mirroring the Zadaxin regimen used in hepatitis trials), often run in 4 to 16 week cycles for general wellness use, with the original clinical trials using 1.6 mg twice weekly for 6 to 12 months
Supports Red Blood Cell Production B12 is necessary for the production of red blood cells, which are responsible for carrying oxygen throughout the body
You can expect an initial test about a week to ten days after you start your injections to see how your body is responding
CJC-1295 & Ipamorelin Blend Product Description CJC-1295 is a long-acting GHRH analog that binds to endogenous albumin, significantly prolonging half-life
Then, weekly injections for a month follow